Table 2 Evolution of the blood test results of our patient under treatment
| Â | Start | 4 months | 12 months |
|---|---|---|---|
Hemoglobin (g/dL) | 7.9 | 8 | 13.8 |
 MCV (fl) | 82 | 68 | 83 |
 MCHC (%) | 30 | 30 | 34 |
Leukocytes (/mm3) | 2510 | 3060 | 2290 |
 Neutrophil (/mm3) | 1000 | 1950 | 970 |
 Lymphocyte (/mm3) | 1120 | 540 | 1060 |
Platelets (/mm3) | 188,000 | 80,000 | 134,000 |
Ferritin (ng/mL) | 10 | 90 | 37 |
C-reactive protein (mg/L) | 4 | 11 | 2 |
Aspartate aminotransferase (UI/L) | 116 | 51 | 24 |
Alanine aminotransferase (UI/L) | 57 | 49 | 14 |
Alkaline phosphatase (UI/L) | 271 | 377 | 287 |
Gamma-glutamyl transferase (UI/L) | 20 | 16 | 20 |
Total bilirubin (mg/L) | 85 | 13 | 3 |
Conjugated bilirubin (mg/L) | 63 | 7 | 2 |
Albumin (g/L) | 22 | 34 | 44 |
Prothrombin time (%) | 43 | 95 | 76 |
Factor V (%) | 41 | – | 56 |
Total cholesterol (g/L) | 0.67 | 0.66 | 0.93 |
HDL (g/L) | 0.05 | 0.24 | 0.32 |
LDL (g/L) | 0.47 | 0.31 | 0.52 |
Triglyceride (g/L) | 0.76 | 0.53 | 0.47 |
TSH (μUI/mL) | 3.15 | – | 1.61 |
T4 (ng/dL) | 1.03 | – | 0.9 |
T3 (pg/mL) | 2.8 | – | 3.15 |
Total protein (g/L) | 64 | 60 | 76 |
Phosphorus (mg/L) | 28 | 48 | 47 |
Corrected calcium (mg/L) | 96 | 101 | 95 |
Vitamin D (ng/mL) | 5 | – | 33 |
Vitamin B9 (ng/mL) | 7.4 | 8.6 | 4.9 |
Vitamin B12 (g/mL) | 1073 | 676 | – |
Vitamin A | NA | NA | NA |
Vitamin E | NA | NA | NA |
Urea (g/L) | 0.19 | 0. 13 | 0.22 |
Creatinine (mg/L) | 4 | 3.7 | 5.5 |
24-h urine protein (g/24h) | 0.06 | – | 0.05 |
Fasting blood sugar (g/L) | 0.75 | 0.78 | 0.9 |
Glycated hemoglobin (%) | 5 | – | 4.7 |
Na+ (mEq/L) | 136 | 138 | 138 |
K+ (mEq/L) | 4.2 | 3.6 | 4.9 |
Cl- (mEq/L) | 107 | 107 | 103 |
HCO3 (mEq/L) | 22 | 25 | 24 |
Alpha-fetoprotein (ng/mL) | 0.89 | 0.56 | 0.50 |
International normalized ratio | 1.57 | 1.03 | 1.11 |